Gastric survival of lactic acid bacteria in probiotic-labelled products from the Turkish market: An in vitro study
| dc.contributor.author | Özlük, G | |
| dc.contributor.author | Krausová, G | |
| dc.date.accessioned | 2026-03-31T13:21:13Z | |
| dc.date.available | 2026-03-31T13:21:13Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | The resilience of lactic acid bacteria (LAB) in commercial probiotic products remains a critical area of investigation, particularly regarding their capacity to survive the harsh gastric environment. Scientific guidelines indicate that at least 6 log CFU center dot g-1 of viable probiotics must reach the intestines to achieve therapeutic benefits, which often requires an initial concentration of 8-9 log CFU center dot g-1 in the product. However, national regulations may specify lower thresholds; for example, Turkish Food Legislation requires 6 log CFU center dot g-1 for probiotic products and 7 log CFU center dot g-1 for kefir products. This study evaluates the in vitro gastric survival of LAB in 20 probiotic-labelled foods and 5 supplements available in the Turkish market using a simulated gastric model. Results reveal that 75% of the marketed probiotic-labelled foods comply with their label claims. Additionally, 55% of the samples demonstrate LAB strains fully resistant to gastric acidity. Dairy-based products exhibit significantly better survival rates under simulated gastric conditions compared to supplements, highlighting their potential for enhanced therapeutic efficacy. | |
| dc.identifier.doi | 10.17221/36/2025-CJFS | |
| dc.identifier.issn | 1212-1800 | |
| dc.identifier.issn | 1805-9317 | |
| dc.identifier.issue | 5 | |
| dc.identifier.uri | http://dx.doi.org/10.17221/36/2025-CJFS | |
| dc.identifier.uri | https://hdl.handle.net/11491/9620 | |
| dc.identifier.volume | 43 | |
| dc.identifier.wos | WOS:001586657100001 | |
| dc.language.iso | en | |
| dc.publisher | CZECH ACADEMY AGRICULTURAL SCIENCES | |
| dc.relation.ispartof | CZECH J FOOD SCI | |
| dc.subject | probiotics | |
| dc.subject | gastrointestinal conditions | |
| dc.subject | legislation | |
| dc.subject | viability | |
| dc.title | Gastric survival of lactic acid bacteria in probiotic-labelled products from the Turkish market: An in vitro study | |
| dc.type | Article |












